Morphine buccal - Generex Biotechnology
Alternative Names: Morphine oral spray - GenerexLatest Information Update: 31 Dec 2021
Price :
$50 *
At a glance
- Originator Generex Biotechnology Corporation
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Pain
Most Recent Events
- 10 Jan 2013 Morphine buccal is available for licensing as of 10 Jan 2013. http://www.generex.com/
- 31 Jul 2009 No development reported - Phase-I for Pain in Canada (Buccal)
- 24 Dec 2004 Generex and Elan agreed to terminate the joint venture to develop buccal morphine